The Leukemia & Lymphoma Society's academic grants support and encourage basic, translational, and clinical blood cancer research.
LLS investigators are outstanding scientists at the forefront of research into hematologic malignancies at centers throughout the world. We award academic grants for studies that range from basic blood cancer discovery science to research that uses the latest tools of genomics.
And we don't stop there. We're also dedicated to funding blood cancer research to help improve the quality of life for patients and their families with our projects studying long-term and late effects.
Check our Research News section for upcoming and currently open funding opportunities!
Get to know some of our Current Grantees and our Current Projects on the main program pages!
You can contact us at [email protected] if you have any questions.
Therapy Acceleration Program® (TAP)
TAP is a mission-driven, strategic venture philanthropy initiative that seeks to accelerate the development of innovative blood cancer therapeutics and change the standard of care while also generating a return on investment for the LLS mission.
TAP collaborates with biotech companies to support the development of novel platforms, first-in-class assets addressing high unmet medical needs, emerging patient populations, and orphan indications.
If you're an academic investigator and know of a biotech company that could benefit from
a collaboration with LLS, learn more about becoming a TAP partner